Senior insider sale
CHIEF EXECUTIVE OFFICER at WHITEHAWK THERAPEUTICS, INC. — senior position signals high conviction
$18.8K
9.69K shares
What this filing means
LENNON DAVID JAMES plans to sell 9.69K shares of WHITEHAWK THERAPEUTICS, INC. valued at approximately $18.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/3/2024ACC: 0001995275-24-000003
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
9.69K
Shares to sell
$18.8K
Approx. market value
32.56K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
10/2/2024
32.56KTotal acquired32.56K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/2/2024 | Restricted Stock Units N/A | 32.56K | — |
| Total | 32.56K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.69K
Market value
$18.8K
10/3/2024
Total
Units
9.69K
Value
$18.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/3/2024 | 9.69K | $18.8K | NASDAQ | Planned |
| Total | 9.69K | $18.8K | ||